Use of ranibizumab for the treatment of subretinal neovascularization in pathologic myopia: a prospective study

Purpose: To determine the efficacy of ranibizumab as a treatment for subretinal neovascularization (SRNV) in pathologic myopia. Materials and Methods: This was an uncontrolled, prospective cohort study, involving 66 pathologic myopic eyes (65 patients) with SRNV. Patients were treated with 0.05-mL (...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: О.M. Blavatska (Autor), T.B. Kustry (Autor), A.R. Korol (Autor)
Format: Knjiga
Izdano: Ukrainian Society of Ophthalmologists, 2016-06-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno